216 related articles for article (PubMed ID: 3924827)
21. Variable region-identical monoclonal antibodies of different IgG subclass directed to Pseudomonas aeruginosa lipopolysaccharide O-specific side chain function differently.
Schreiber JR; Cooper LJ; Diehn S; Dahlhauser PA; Tosi MF; Glass DD; Patawaran M; Greenspan NS
J Infect Dis; 1993 Jan; 167(1):221-6. PubMed ID: 8418172
[TBL] [Abstract][Full Text] [Related]
22. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
[TBL] [Abstract][Full Text] [Related]
23. Nonopsonic phagocytosis of nonmucoid Pseudomonas aeruginosa by human neutrophils and monocyte-derived macrophages is correlated with bacterial piliation and hydrophobicity.
Speert DP; Loh BA; Cabral DA; Salit IE
Infect Immun; 1986 Jul; 53(1):207-12. PubMed ID: 2873104
[TBL] [Abstract][Full Text] [Related]
24. Binding of the capsule-like serotype-specific polysaccharide antigen and the lipopolysaccharide from Actinobacillus actinomycetemcomitans to human complement-derived opsonins.
Yamaguchi N; Tsuda H; Yamashita Y; Koga T
Oral Microbiol Immunol; 1998 Dec; 13(6):348-54. PubMed ID: 9872110
[TBL] [Abstract][Full Text] [Related]
25. Effect of Haemophilus influenzae type b lipopolysaccharide on complement activation and polymorphonuclear leukocyte function.
Inzana TJ; Tosi MF; Kaplan SL; Anderson DC; Mason EO; Williams RP
Pediatr Res; 1987 Dec; 22(6):659-66. PubMed ID: 3324033
[TBL] [Abstract][Full Text] [Related]
26. Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways.
Laarman AJ; Bardoel BW; Ruyken M; Fernie J; Milder FJ; van Strijp JA; Rooijakkers SH
J Immunol; 2012 Jan; 188(1):386-93. PubMed ID: 22131330
[TBL] [Abstract][Full Text] [Related]
27. Phagocytosis and killing of Pseudomonas aeruginosa by mouse polymorphonuclear leukocytes in vitro promoted by antiserum to the slime glycolipoprotein.
Bishop O; Orr T; Bartell PF
Infect Immun; 1982 Jul; 37(1):378-81. PubMed ID: 6809634
[TBL] [Abstract][Full Text] [Related]
28. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
Cryz SJ; Meadow PM; Fürer E; Germanier R
Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605
[TBL] [Abstract][Full Text] [Related]
29. Influence of lipopolysaccharide chemotype on the interaction between Klebsiella pneumoniae and human polymorphonuclear leucocytes.
Williams P; Ciurana B; Camprubi S; Tomas JM
FEMS Microbiol Lett; 1990 Jun; 57(3):305-9. PubMed ID: 1698690
[TBL] [Abstract][Full Text] [Related]
30. Complement activation by Pseudomonas aeruginosa biofilms.
Jensen ET; Kharazmi A; Garred P; Kronborg G; Fomsgaard A; Mollnes TE; Høiby N
Microb Pathog; 1993 Nov; 15(5):377-88. PubMed ID: 8015418
[TBL] [Abstract][Full Text] [Related]
31. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa.
Meshulam T; Obedeanu N; Merzbach D; Sobel JD
Clin Immunol Immunopathol; 1984 Aug; 32(2):151-65. PubMed ID: 6428788
[TBL] [Abstract][Full Text] [Related]
32. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa.
Pier GB; Thomas DM
J Infect Dis; 1983 Aug; 148(2):206-13. PubMed ID: 6411830
[TBL] [Abstract][Full Text] [Related]
35. Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.
Milatovic D
Eur J Clin Microbiol; 1984 Aug; 3(4):288-93. PubMed ID: 6436020
[TBL] [Abstract][Full Text] [Related]
36. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes.
Sandström G; Löfgren S; Tärnvik A
Infect Immun; 1988 May; 56(5):1194-202. PubMed ID: 3356465
[TBL] [Abstract][Full Text] [Related]
37. Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.
Schiller NL; Hatch RA; Joiner KA
Infect Immun; 1989 Jun; 57(6):1707-13. PubMed ID: 2498205
[TBL] [Abstract][Full Text] [Related]
38. Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.
Thomsen K; Christophersen L; Jensen PØ; Bjarnsholt T; Moser C; Høiby N
Hum Vaccin Immunother; 2016 Jul; 12(7):1690-9. PubMed ID: 26901841
[TBL] [Abstract][Full Text] [Related]
39. The role of antibody and complement in phagocytosis by rabbit alveolar macrophages.
Murphey SA; Root RK; Schreiber AD
J Infect Dis; 1979 Dec; 140(6):896-903. PubMed ID: 120385
[TBL] [Abstract][Full Text] [Related]
40. C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae.
Grossman N; Joiner KA; Frank MM; Leive L
J Immunol; 1986 Mar; 136(6):2208-15. PubMed ID: 3950413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
